Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-31T06:15:02

Saxagliptin (5mg), Metformin HCI (ER) (500mg) GLISAXAPIN M 5/500 Saxagliptin and metformin hydrochloride extended-release (ER) are two medications used in GLISAXAPIN M 5/500 to manage high blood sugar levels in people with type 2 diabetes. GLISAXAPIN M 5/500 often prescribed in combination when diet and exercise alone are insufficient to control blood glucose levels. Let's look at each medication individually: Saxagliptin: Saxagliptin is an oral antidiabetic medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). Incretins help regulate blood sugar by stimulating the release of insulin and suppressing the release of glucagon after meals. Saxagliptin helps increase insulin secretion and decrease glucagon production, leading to improved blood sugar control. Metformin Hydrochloride (ER): Metformin is a widely used medication in the treatment of type 2 diabetes. It belongs to the class of drugs called biguanides and works primarily by reducing the amount of sugar produced by the liver and increasing the sensitivity of muscle cells to insulin. Metformin can help lower fasting blood sugar levels and improve insulin utilization in the body. The "ER" in metformin HCI (ER) stands for "extended-release, " which means the medication is released slowly over time, allowing for once-daily dosing. The combination of saxagliptin and metformin HCI (ER) is often prescribed to provide complementary mechanisms of action to control blood sugar levels in individuals with type 2 diabetes. Saxagliptin helps enhance post-meal insulin secretion, while metformin primarily addresses fasting blood sugar and insulin resistance. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/glisaxapin-m-5-500-133434

Saxagliptin (5mg), Metformin HCI (ER) (500mg) GLISAXAPIN M 5/500 Saxagliptin and metformin hydrochloride extended-release (ER) are two medications used in GLISAXAPIN M 5/500 to manage high blood sugar levels in people with type 2 diabetes. GLISAXAPIN M 5/500 often prescribed in combination when diet and exercise alone are insufficient to control blood glucose levels. Let's look at each medication individually: Saxagliptin: Saxagliptin is an oral antidiabetic medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). Incretins help regulate blood sugar by stimulating the release of insulin and suppressing the release of glucagon after meals. Saxagliptin helps increase insulin secretion and decrease glucagon production, leading to improved blood sugar control. Metformin Hydrochloride (ER): Metformin is a widely used medication in the treatment of type 2 diabetes. It belongs to the class of drugs called biguanides and works primarily by reducing the amount of sugar produced by the liver and increasing the sensitivity of muscle cells to insulin. Metformin can help lower fasting blood sugar levels and improve insulin utilization in the body. The "ER" in metformin HCI (ER) stands for "extended-release, " which means the medication is released slowly over time, allowing for once-daily dosing. The combination of saxagliptin and metformin HCI (ER) is often prescribed to provide complementary mechanisms of action to control blood sugar levels in individuals with type 2 diabetes. Saxagliptin helps enhance post-meal insulin secretion, while metformin primarily addresses fasting blood sugar and insulin resistance. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/glisaxapin-m-5-500-133434

  • 2024-01-31T06:15:02

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us